Found 13 matching trials
Neoadjuvant Treatment of Breast Cancer N/A Observational investigation of participants who are given neoadjuvant treat...
Show More Location
National Institute of Oncolgy
Learn More & Join Trial
OFS in Premenopausal Node+ Breast Cancer With Low Genomic Risk PHASE4 Among ER+HER2- premenopausal patients with N1 who undergoes primary breast ...
Show More Location
Gangnam Severance Hospital
Learn More & Join Trial
A Study Evaluating the Efficacy and Safety of Adjuvant Giredestrant Compared With Physician's Choice of Adjuvant Endocrine Monotherapy in Participants With Estrogen Receptor-Positive, HER2-Negative Early Breast Cancer (lidERA Breast Cancer) PHASE3 This is a Phase III, global, randomized, open-label, multicenter, study eva...
Show More Status
Active Not Recruiting
Location
Southern Cancer Center
Learn More & Join Trial
Adjuvant Ovarian Suppression Plus Aromatase Inhibitor or Tamoxifen in Young Women PHASE3 The objective of this study is to compare the curative effects in patients ...
Show More Location
Cancer Hospital Chinese Academy of Medical Sciences
Learn More & Join Trial
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer PHASE3 RATIONALE: Estrogen can cause the growth of breast cancer cells. Hormone th...
Show More Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Learn More & Join Trial
Neoadjuvant Endocrine Therapy in Breast Cancer. Real Clinical Practice in Russia N/A Neoadjuvant Endocrine Therapy for pre- and postmenopausal women with T4 Nan...
Show More Location
Blokhin's Russian Cancer Research Center
Learn More & Join Trial
Tolerability of Dalpiciclib vs. Abemaciclib/Ribociclib in Early HR+/HER2- Breast Cancer NA In recent years, the successful application of cyclin-dependent kinase 4/6 ...
Show More Location
Multiple Locations
Learn More & Join Trial
Neoadjuvant Response-guided Treatment of Luminal B-type Tumors and Luminal A-type Tumors With Node Metastases PHASE2 The purpose of this neoadjuvant trial is to evaluate efficacy and toxicity ...
Show More Status
Active Not Recruiting
Learn More & Join Trial
Impact of Formulation Change on Ovarian Suppression in Young Breast Cancer Patients. PHASE2 This is a multicenter, prospective, randomized controlled, phase II study. ...
Show More Location
Multiple Locations
Learn More & Join Trial
Study of Efficacy and Safety in Premenopausal Women With Hormone Receptor Positive, HER2-negative Advanced Breast Cancer PHASE3 The purpose of this study was to determine whether treatment with tamoxifen...
Show More Location
Comprehensive Blood and Cancer SC-2
Learn More & Join Trial